Since the late 1970s, topical β‐adrenergic blockers have been the drugs of choice in
treating ocular hypertension and associated glaucoma. The currently available drugs are …

Timolol maleate, a nonselective beta blocker, has been associated with adverse reactions
when administered topically or systemically. The current literature pertaining to timolol …

• Betaxolol hydrochloride, 0.5%, and timolol maleate, 0.5%, were compared in a 26-week
randomized, double-masked study involving 46 patients with primary open-angle glaucoma …

To evaluate the effects of two beta-adrenergic blocking agents on cardiopulmonary function,
we investigated two topical ophthalmologic preparations, betaxolol 1% and timolol 0.5%, in …

Timolol is a commonly-used topical antiglaucoma medication and has proven to be highly
efficacious for most recipients. Among the reported adverse events, the neuropsychiatric …

Background Eye-drop administration errors occur in the majority of patients and increase the
risk for treatment failure or systemic adverse events. While lacking knowledge is the …

Glaucoma and ocular hypertension are highly prevalent conditions in individuals over the
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …

PURPOSE: Topical beta-blocker treatment is routine therapy in the management of patients
with glaucoma. Therapy results in systemic absorption, however, the degree of reduction of …

Objective: This study evaluated systemic and ocular acute safety and intraocular pressure
(IOP)-lowering efficacy of travoprost 0.004% and bimatoprost 0.03%, compared to …

Discussion It is certainly a tragedy when a patient hospitalized for minor surgery dies. Airway
reactivity in those with asthma differs from patient to patient and, indeed, even in the same …